Loading...
•
Dec 31, 2020
Balchem Q4 2020 Earnings Report
Reported record Q4 sales and increased net earnings compared to the previous year.
Key Takeaways
Balchem Corporation reported record fourth-quarter sales of $180.7 million, an 8.5% increase year-over-year. Net earnings were $22.2 million, up from $20.4 million in the prior year. GAAP EPS was $0.68, while adjusted EPS reached $0.83. The company experienced sales growth across all three segments.
Record net sales of $180.7 million, an 8.5% increase compared to the prior year quarter.
Adjusted EBITDA reached a record $43.6 million, an 8.9% increase from the prior year.
GAAP net earnings increased by 8.7% to $22.2 million, resulting in GAAP earnings per share of $0.68.
Cash flows from operations increased to $48.0 million, with quarterly free cash flow of $35.0 million.
Balchem
Balchem
Balchem Revenue by Segment
Revenue by Segment
Human Nutrition & Health Revenue
CapyFin.comAnimal Nutrition & Health Revenue
CapyFin.comSpecialty Products Revenue
CapyFin.com Forward Guidance
Balchem is well-positioned to continue driving growth and further strengthen its strategic position in 2021.
Positive Outlook
- Strong cash flows enabled debt repayments.
- Successfully added three additional sites onto the new ERP system.
- COVID-19 response focused on employee safety and operational continuity.
- Declared an 11.5% increase in the dividend on common stock.
- The company is well positioned to drive growth into the future.
Revenue & Expenses
Visualization of income flow from segment revenue to net income